Your browser doesn't support javascript.
loading
Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond Replacement.
Tsuji, Kohei; Kobayakawa, Takuya; Ishii, Takahiro; Higashi-Kuwata, Nobuyo; Azuma, Chika; Shinohara, Kouki; Miura, Yutaro; Yamamoto, Kenichi; Nishimura, Soshi; Hattori, Shin-Ichiro; Bulut, Haydar; Mitsuya, Hiroaki; Tamamura, Hirokazu.
Afiliação
  • Tsuji K; Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU).
  • Kobayakawa T; Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU).
  • Ishii T; Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU).
  • Higashi-Kuwata N; Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute.
  • Azuma C; Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU).
  • Shinohara K; Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU).
  • Miura Y; Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU).
  • Yamamoto K; Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU).
  • Nishimura S; Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU).
  • Hattori SI; Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute.
  • Bulut H; Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health.
  • Mitsuya H; Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute.
  • Tamamura H; Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health.
Chem Pharm Bull (Tokyo) ; 71(12): 879-886, 2023.
Article em En | MEDLINE | ID: mdl-38044140
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article